CAS 204060-43-5 MART-1nonamerantigen

Send Inquiry
CAS 204060-43-5 MART-1nonamerantigen
Details
MART-1/Melan-A nonamer epitope;
Category: Tumor differentiation antigen / HLA-A2 melanoma CTL epitope.
Peptide Purity (HPLC) ≥95%
CAS No. 204060-43-5
Structure Linear 9-mer (MART-1 nonamer, HLA-A2)
Solubility DMSO/water cosolvent, PBS
Storage Powder, −20°C, dry, light-protected
Category
Epitope Peptides
Share to
Description

Shanghai Sonyt Biotechnology Co., Ltd. is one of the leading manufacturers and suppliers of cas 204060-43-5 mart-1nonamerantigen in China, also supports custom service. Welcome to wholesale bulk high quality cas 204060-43-5 mart-1nonamerantigen from our factory. Contact us for more details.

 

Description The MART-1/Melan-A 9-mer HLA-A2 epitope, one of the most-recognized melanoma self-antigens; used for vaccines and ACT.

 

Product Basic Information Table

 

Product Standard English Name Product Abbreviation / Alias Function Tags (comma-separated) Core Structure (Sequence) Molecular Formula Exact Mass (Da) Average MW (Da) Salt Form Length (aa)
MART-1/Melan-A nonamer antigen (A27L superagonist) (CAS 204060-43-5) MART-1 nonamer antigen; Melan-A/MART-1 A27L heteroclitic peptide; LAGIGILTV; superagonist variant of MART1/Melan-A27-35 Tumor antigen peptide, HLA-A*0201 restricted, CD8+ CTL, melanoma, superagonist analog, anticancer vaccine Linear 9-mer, free N-terminus (H-), free C-terminal carboxyl (-OH), no side-chain modification. IMPORTANT: this CAS corresponds to LAGIGILTV (the position-27 Ala→Leu modified analog), NOT the native MART-1(27-35)=AAGIGILTV. C40H73N9O11 855.54 856.07 TFA salt (typical, per COA) 9

 

Physicochemical Solubility & Storage Parameters

 

Product Code Appearance Long-term Storage Short-term Storage Solution Stability Solid Powder Stability
PEP-MART1NON-01 White to off-white powder. Long-term -20 °C dry and sealed; short-term 2-8 °C. Aliquot after reconstitution; avoid repeated freeze-thaw and moisture uptake. Long-term -20 °C dry and sealed; short-term 2-8 °C. Aliquot after reconstitution; avoid repeated freeze-thaw and moisture uptake. Highly hydrophobic (rich in aliphatic L/A/I/V); poorly water-soluble. First dissolve in DMSO or DMF to a 1-10 mg/mL stock, then dilute into medium/buffer. Stable as solid; hydrophobic peptides cake on moisture-store dry.

 

Functional Description

 

Product Code Frontend Short Summary Detailed Biological Function Description Applicable Research Areas (comma-separated) Targets / Pathways
PEP-MART1NON-01 The MART-1 nonamer antigen (LAGIGILTV) is the A27L superagonist analog of the melanoma antigen MART-1/Melan-A 27-35; it binds HLA-A*0201 more tightly and elicits more potent antitumor CD8+ T cells, serving as a model peptide for cancer-vaccine and CTL studies. MART-1 (Melan-A) is a melanoma-specific differentiation antigen; its immunodominant, HLA-A*0201-restricted epitope recognized by most tumor-infiltrating lymphocytes is the nonapeptide AAGIGILTV (residues 27-35). This product (CAS 204060-43-5) is the A27L modified analog LAGIGILTV: replacing the N-terminal anchor position (P2) Ala with Leu greatly improves HLA-A*0201 binding affinity/stability, creating a heteroclitic superagonist. Rivoltini et al. (Cancer Res, 1999) showed it elicits CD8+ T cells with enhanced IFN-γ secretion and cytolytic function that cross-recognize the native MART-1 epitope. It is widely used for HLA-A2+ melanoma vaccine design, in vitro CTL priming/expansion, pMHC-I tetramer reagents, adoptive T-cell therapy, and tumor-immune monitoring. Distinguish it from the native nonapeptide AAGIGILTV (different CAS). Tumor immunology, melanoma, HLA-A*0201, CD8+ CTL, cancer vaccine, adoptive T-cell therapy HLA-A*0201 (MHC class I); MART-1-specific CD8+ TCR

 

 

 

 

Hot Tags: cas 204060-43-5 mart-1nonamerantigen, China cas 204060-43-5 mart-1nonamerantigen manufacturers, suppliers, factory, Ac MBP 1 11 , BCMA72-80, CAS 125366 42 9, CAS 2293841 58 2, CAS 265669 37 2, Nucleoprotein 118 126

Send Inquiry